Kasabach-Merritt Syndrome D059885

Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Vascular Tissue » Hemangioma » Kasabach-Merritt Syndrome

Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Blood Platelet Disorders » Thrombocytopenia » Kasabach-Merritt Syndrome

Description

Rapidly growing vascular lesion along the midline axis of the neck, upper trunk, and extremities that is characterized by CONSUMPTION COAGULOPATHY; THROMBOCYTOPENIA; and HEMOLYTIC ANEMIA. It is often associated with infantile Kaposiform HEMANGIOENDOTHELIOMA and other vascular tumors such as tufted ANGIOMA.   MeSH

Hierarchy View


Phase 4 Indicated Drugs (1)

Phase 2 Indicated Drugs (2)


Organization Involved with Phase 4 Indications (2)

Organization Involved with Phase 2 Indications (3)

Organization Involved with Phase 1 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.